Substance use disorders in patients with posttraumatic stress disorder: A review of the literature

American Journal of Psychiatry

Volumn 158, Issue 8, 2001, Pages 1184-1190

  Jacobsen, L K ^a   Southwick, S M ^a   Kosten, T R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; HYPNOTIC AGENT; NORADRENALIN; SEDATIVE AGENT;

ALCOHOL ABUSE; COMORBIDITY; DISEASE ASSOCIATION; DRUG DETOXIFICATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PHENOMENOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RELAPSE; REVIEW; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADULT; ANIMALS; AROUSAL; COMORBIDITY; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; HYDROCORTISONE; NOREPINEPHRINE; RATS; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0034893510     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.8.1184     Document Type: Review

References (69)

1. Posttraumatic stress disorder in the National Comorbidity Survey
2. Traumatic events and posttraumatic stress disorder in an urban population of young adults
3. Psychiatric sequelae of posttraumatic stress disorder in women
4. Posttraumatic stress disorder among substance users from the general population
5. Prevalence of victimization and posttraumatic stress disorder among women with substance use disorders: Comparison of telephone and in-person assessment samples
6. The frequency and impact of violent trauma among pregnant substance abusers
7. Prevalence and risk factors for posttraumatic stress disorder among chemically dependent adolescents
8. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study
9. Understanding comorbidity between PTSD and substance use disorders: Two preliminary investigations
10. Course and treatment of patients with both substance use and posttraumatic stress disorders
11. Posttraumatic stress disorder and cocaine dependence
12. Enhanced sensitivity to negative glucocorticoid feedback in methadone patients with ongoing cocaine dependence
13. Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse
14. Inescapable shock, neurotransmitters, and addiction to trauma: Toward a psychobiology of post traumatic stress
15. Prepulse inhibition of the startle reflex: Preliminary study of the effects of a low dose of alcohol in humans
16. Combat zone adjustment: The role of marihuana use
17. The interrelationship of substance abuse and posttraumatic stress disorder: Epidemiological and clinical considerations
18. Posttraumatic stress disorder and drug disorders: Testing causal pathways
19. Corticotropin-releasing factor, norepinephrine, and stress
20. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction
21. Stress-induced craving and stress response in cocaine dependent individuals
22. Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal
23. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period
24. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration
25. Glucocorticoids and behavioral effects of psychostimulants, II: Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels
26. Central administration of corticotropin releasing factor induces long-term sensitization to d-amphetamine
27. Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization
28. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats
29. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats
30. Corticotropin-releasing factor release from mediobasal hypothalamus of the rat as measured by microdialysis
31. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence
32. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats
33. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor 1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
34. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia
35. Urinary free-cortisol levels in posttraumatic stress disorder patients
36. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder
37. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder
38. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder
39. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder
40. Effects of controllable vs uncontrollable chronic stress on stress-responsive plasma hormones
41. Central norepinephrine and plasma corticosterone following acute and chronic stressors: Influence of social isolation and handling
42. Stress adaptation and adrenal activity in isolated and crowded rats
43. Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats
44. Stress-restress: Effects on ACTH and fast feedback
45. Induction of corticotropin-releasing hormone gene expression by glucocorticoids; implication for understanding the states of fear and anxiety and allostatic load
46. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus
47. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus
48. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder
49. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41)
50. Noradrenaline release in the rat amygdala is increased by stress: Studies with intracerebral microdialysis
51. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
52. Plasma noradrenaline, platelet alpha 2-adrenoceptors, and functional scores during ethanol withdrawal
53. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal: Correlations with clinical signs
54. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: Evidence for noradrenergic hyperactivity
55. Brain catecholamine metabolites and behavior in morphine withdrawal
56. Clonidine treatment of the opiate withdrawal syndrome: A review of clinical trials of a theory
57. Clonidine for posttraumatic stress disorder in preschool children
58. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
59. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus
60. Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltametry
61. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis
62. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor
63. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: In vivo microdialysis studies
64. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
65. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling: Comparison with the hypothalamic response
66. Kindling versus quenching; implications for the evolution and treatment of posttraumatic stress disorder
67. Biological mechanisms in posttraumatic stress disorder: Relevance for substance abuse
68. Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: Evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1